Technology | March 14, 2011

Vascular Graft Receives CE Mark

March 14, 2011 – A vascular graft for hemodialysis access has received the CE mark. The Gore Propaten vascular graft, from W.L. Gore and Associates, utilizes a covalent bonding technology to adhere heparin to the graft surface.

Arteriovenous (AV) grafts are used to create a conduit for repeated blood access during hemodialysis, allowing blood to be withdrawn from the body and cleansed when a patient has end stage renal disease (ESRD), commonly referred to as kidney failure. During the implantation procedure, a vascular graft is implanted through two small incisions in the arm. Once a tunnel is created under the skin, one end of the vascular graft is sewn to the artery and the other to the vein. Blood can then flow rapidly from the artery through the vascular graft into the vein, producing the higher flow rates needed for the hemodialysis process.

The Carmeda BioActive Surface (CBAS) activity has demonstrated long-lasting effectiveness in a clinical explant of up to three years after implantation. It allows blood flowing through the graft to resist thrombosis or clotting. The graft is composed of an expanded polytetrafluoroethylene (ePTFE) material with excellent handling properties and flexibility for ease of use.

The device has been used in lower extremity applications in the United States since 2006 and in Europe for more than 10 years, with a reported one-year primary patency in below-knee bypasses of 80 percent, compared with 66 percent for standard ePTFE and 81 percent for autologous vein bypasses. With more than 18,000 dialysis access implants worldwide, it is the only vascular graft of its kind on the market approved for hemodialysis access. Interim results of a prospective, nonrandomized study comparing it to a non heparin-bonded graft in high-risk patients for hemodialysis access application found that the Gore Propaten vascular grafts have a significant improvement of 20 percent in clot-free survival compared to the control group.

“This is forward progress in adding a new bioactive technology to address the graft failure mode of thrombosis. The Gore Propaten vascular graft has been successfully demonstrated in the lower extremities, and it is an exciting new option for hemodialysis use,” said Eric Chemla, M.D., consultant renal transplant and vascular surgeon, St. George’s Healthcare U.K. National Health Service (NHS) Trust.

The graft is now available in multiple configurations, including 4 – 7 mm tapers and integrated rings. The cross-sectional profile is reduced by approximately 24 percent when compared to an externally ringed vascular graft.

For more information: www.goremedical.com

Related Content

An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. Photo by Dave Fornell

An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. Photo by Dave Fornell

Feature | Interventional Radiology | April 03, 2020 | By Katie Caron
A new year — and decade — offers the opportunity to reflect on the advancements and challenges of years gone by and p
COVID-19 outbreak in Seattle cancels SIR 2020 meeting. Interventional radiology meeting cancelled. #COVID19 #coronavirus #2019nCoV
News | Interventional Radiology | March 09, 2020 | Melinda Taschetta-Millane
March 9, 2020 — As the novel coronavirus (COVID-19) slowly spreads across the globe, more industry conferences are de
DSA image obtained approximately 24 hours after 1 mg/h IA tPA infusion, 500 U/h heparin via peripheral IV, and daily oral aspirin (81 mg) shows improved perfusion of digital arteries, albeit with suboptimal vascular blush of distal second and third phalanges. Photo courtesy of ARRS

DSA image obtained approximately 24 hours after 1 mg/h IA tPA infusion, 500 U/h heparin via peripheral IV, and daily oral aspirin (81 mg) shows improved perfusion of digital arteries, albeit with suboptimal vascular blush of distal second and third phalanges. Photo courtesy of ARRS

News | Interventional Radiology | February 11, 2020
February 11, 2020 — An ahead-of-print...
New SIR position statement and quality documents highlight interventional radiology effective use of nonsurgical ablation to treat kidney cancer in selected patients
News | Interventional Radiology | February 04, 2020
February 4, 2020 — For some patients, kidney cancer can be effectively treated without surgery, according to the Soci
Smart Speaker Technology Harnessed for Hospital Medical Treatments
News | Interventional Radiology | April 10, 2019
Smart speakers customarily used in your living room can act as an aid to physicians in hospital operating rooms,...
NZ Technologies Announces First Peer-Reviewed Paper on TIPSO AirPad
News | Interventional Radiology | March 25, 2019
NZ Technologies Inc. announced the first published clinical review on its TIPSO technology’s ability to provide...
Embolx Announces FDA Clearance of Next-generation Sniper Balloon Occlusion Microcatheter
Technology | Interventional Radiology | June 29, 2018
Embolx Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its next-generation...
Guerbet Launches Pair of Microcatheters for Interventional Radiology Procedures
Technology | Interventional Radiology | May 23, 2018
Guerbet LLC USA announced the upcoming launch of SeQure and DraKon, two novel microcatheters for tumor and vascular...
U.S. First Lady Melania Trump Undergoes Interventional Radiology Embolization Procedure
News | Interventional Radiology | May 15, 2018
U.S. First Lady Melania Trump underwent an interventional radiology embolization procedure to treat a benign kidney...